Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm
Crossref DOI link: https://doi.org/10.1007/s00508-016-1091-9
Published Online: 2016-10-14
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Füreder, Wolfgang
Cerny-Reiterer, Sabine
Sperr, Wolfgang R.
Müllauer, Leonhard
Jäger, Eva
Schwarzinger, Ilse
Geissler, Klaus
Valent, Peter
License valid from 2016-10-14